Compare PRME & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRME | AMN |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Assisted Living Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 731.0M |
| IPO Year | 2022 | 2001 |
| Metric | PRME | AMN |
|---|---|---|
| Price | $2.84 | $26.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $7.56 | ★ $22.25 |
| AVG Volume (30 Days) | ★ 2.2M | 1.1M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.18 | ★ 35.58 |
| EPS | N/A | ★ 1.59 |
| Revenue | $4,632,000.00 | ★ $1,988,454,000.00 |
| Revenue This Year | $7.06 | $17.27 |
| Revenue Next Year | $47.01 | N/A |
| P/E Ratio | ★ N/A | $16.98 |
| Revenue Growth | ★ 55.28 | 4.53 |
| 52 Week Low | $1.11 | $14.97 |
| 52 Week High | $6.94 | $31.65 |
| Indicator | PRME | AMN |
|---|---|---|
| Relative Strength Index (RSI) | 33.53 | 59.09 |
| Support Level | N/A | $16.68 |
| Resistance Level | $3.97 | $31.65 |
| Average True Range (ATR) | 0.24 | 1.90 |
| MACD | -0.06 | 0.14 |
| Stochastic Oscillator | 16.94 | 56.51 |
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.